Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma

Clinical and Experimental Immunology

Volumn 172, Issue 3, 2013, Pages 507-512

  Hanafusa, T ^a   Matsui, S ^a   Murota, H ^a   Tani, M ^a   Igawa, K ^a   Katayama, I ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopy; Immunohistochemistry immunohistology; Leukaemia lymphoma myeloma

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; SERUM SOLUBLE INTERLEUKIN 2 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL COUNT; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; REFERENCE VALUE; REGULATORY T LYMPHOCYTE; SKIN BIOPSY;

EID: 84876737555     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12073     Document Type: Article

References (10)

1. Katayama I, Kohno Y, Akiyama K etal. Japanese guideline for atopic dermatitis. Allergol Int 2011; 60:205-220.
2. Wollina U. Cutaneous T cell lymphoma: update on treatment. Int J Dermatol 2012; 51:1019-1036.
3. Sokolowska-Wojdylo M, Baranska-Rybak W, Cegielska A, Trzeciak M, Lugowska-Umer H, Gniadecki R. Atopic dermatitis-like pre-Sezary syndrome: role of immunosuppression. Acta Derm Venereol 2011; 91:574-577.
4. Hanafusa T, Azukizawa H, Kitaba S etal. Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course. Clin Exp Immunol 2011; 166:164-170.
5. Roncador G, Brown PJ, Maestre L etal. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunogenet 2005; 35:1681-1691.
6. Rensing-Ehl A, Gaus B, Bruckner-Tuderman L, Martin SF. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid. Exp Dermatol 2007; 16:13-21.
7. Neish C, Charlry M, Jegasothy B, Tharp M, Deng JS. Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases. J Dermatol Sci 1994; 8:11-17.
8. Vonderheid EC, Zhang Q, Lessin SR etal. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998; 38:207-220.
9. Miyagaki T, Sugaya M. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis. J Dermatol Sci 2011; 64:1-6.
10. Miyagaki T, Sugaya M, Suga H etal. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels. J Eur Acad Dermatol Venereol 2013; 27:19-24.